Thrombolysis in a Stroke Patient on Dabigatran Anticoagulation: Case Report and Synopsis of Published Cases
Open Access
- 25 March 2013
- journal article
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 5 (1) , 56-61
Abstract
We present the case of an aphasic 77-year-old stroke patient with left distal M1 occlusion who received rt-PA for thrombolysis while on oral anticoagulant treatment with dabigatran (150 mg b.i.d.). Coagulation parameters were normal (thrombin time 20 s, aPTT 20 s, INR 1.08) and the patient improved from an NIHSS of 15 to 5 within 24 h with sonographic evidence of M1 recanalization. She did not develop intracranial bleeding complications but showed unusually large diffuse skin ecchymoses. In our report, we give an overview of all reported cases of thrombolysis under dabigatran anticoagulation and discuss the questions of medication adherence under novel oral anticoagulants (NOA) and the safety of NOA in terms of secondary intracerebral hemorrhage after stroke.Keywords
This publication has 24 references indexed in Scilit:
- Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patientsInternational Journal of Cardiology, 2013
- Secondary Intracerebral Hemorrhage Due to Early Initiation of Oral Anticoagulation After Ischemic StrokeStroke, 2012
- Acute Ischemic Stroke Treated with Intravenous Tissue Plasminogen Activator in a Patient Taking Dabigatran with Radiographic Evidence of RecanalizationJournal of Stroke and Cerebrovascular Diseases, 2012
- Intravenous Thrombolysis in a Stroke Patient Taking DabigatranJournal of Stroke and Cerebrovascular Diseases, 2012
- Thrombolysis in an Ischemic Stroke Patient on Dabigatran Anticoagulation: A Case ReportCerebrovascular Diseases, 2012
- No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic StrokePLOS ONE, 2012
- Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental strokeAnnals of Neurology, 2012
- Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration timeThrombosis and Haemostasis, 2011
- Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatranThrombosis and Haemostasis, 2011
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activityThrombosis and Haemostasis, 2010